BioMind X 60 Vegetable Capsules
Regular price
Rs. 38,671
- Unit price
- per
100% Authentic
Made in USA
Authorised distributor
1-5 Days delivery
BioMind X 60 Vegetable Capsules
Regular price
Rs. 38,671
- Unit price
- per
Price includes all duties and taxes
SKU: SUPP-BIOMIND
FMI's Choice
BioMind - Advanced Neurocognitive Research Complex
Exploring Cognitive Function, Neuroprotection, and Synaptic Plasticity
BioMind is a three-in-one research formulation developed to investigate pathways of neuroplasticity, cognitive resilience, and brain health in preclinical settings. It combines J-147, Dihexa, and Noopept - three complementary neuroactive compounds that together provide a unique framework for studying neural regeneration and cognitive performance.
Key Components of BioMind
- J-147 (10mg per serving*): A neurotrophic compound studied for its ability to modulate mitochondrial function, increase BDNF, and support resilience against oxidative stress.
- Dihexa (10mg per serving*): A synaptogenic agent that promotes neural connectivity and repair, mimicking natural neurotrophic factors.
- Noopept (10mg per serving*): A dipeptide nootropic that supports neurotransmission, memory formation, and neuronal protection.
*Serving size = 2 capsules
Research Focus Areas
- J-147: Investigated for mitochondrial modulation, neuroprotection, and pathways linked to longevity and cognitive resilience.
- Dihexa: Explored for synaptogenesis, neural repair, and enhanced long-term potentiation (LTP).
- Noopept: Studied for its role in neurotransmission, neuroprotection, and cognitive support.
Synergistic Potential
Together, J-147, Dihexa, and Noopept create a multi-target research platform:
- J-147 enhances mitochondrial function and BDNF expression.
- Dihexa promotes synaptic repair and connectivity.
- Noopept amplifies neurotransmission efficiency and memory processes.
This synergy provides a valuable opportunity to study mechanisms of neurodegeneration, cognitive enhancement, and neuronal repair in preclinical models.
Research Insights
J147 and Neuroprotection
J147 is a synthetic compound designed to combat neurodegenerative diseases, particularly Alzheimer’s disease. It has demonstrated the ability to reverse cognitive impairment in aged Alzheimer’s disease mouse models by enhancing memory and synaptic plasticity [1]. Further studies indicate that J147 improves mitochondrial function and reduces markers of brain aging, suggesting its potential as a therapeutic agent for neurodegenerative conditions [2].
Dihexa and Synaptic Growth
Dihexa is an angiotensin IV analog known for its potent neurogenic and synaptogenic effects. Research has shown that Dihexa binds with high affinity to hepatocyte growth factor (HGF), promoting synaptogenesis and enhancing cognitive function in animal models of Alzheimer’s disease [3]. In APP/PS1 mouse models, Dihexa administration rescued cognitive impairment and recovered memory via the PI3K/AKT signaling pathway [4].
Noopept and Cognitive Enhancement
Noopept is a synthetic nootropic compound recognized for its cognitive-enhancing properties. Studies have demonstrated that Noopept improves memory retention and learning capacity in animal models, suggesting its potential in addressing cognitive decline associated with aging and neurodegenerative diseases [5]. Its mechanisms include modulation of glutamatergic transmission and increased expression of neurotrophic factors, which contribute to its neuroprotective and cognitive-enhancing effects [5].
Synergistic Effects of J147, Dihexa, and Noopept
BioMind’s unique formulation combines J147’s neuroprotective properties, Dihexa’s synaptogenic effects, and Noopept’s cognitive enhancement, creating a comprehensive approach to support brain health and function. This synergistic combination offers a multifaceted strategy for promoting neuronal resilience and cognitive performance, addressing synaptic loss, cognitive decline, and neuronal damage concurrently.
Referenced Citations
- Chen, Q., et al. (2013). “The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer’s disease mice.” Alzheimer’s Research & Therapy, 5, 25.
- Currais, A., et al. (2019). “Elevating acetyl-CoA levels reduces aspects of brain aging.” eLife, 8, e47866.
- Benoist, C. C., et al. (2014). “The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-Met system.” Journal of Pharmacology and Experimental Therapeutics, 351(2), 390–402.
- Sun, X., et al. (2021). “AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway.” Frontiers in Aging Neuroscience, 13, 745.
- Ostrovskaya, R. U., et al. (2014). “Neuroprotective properties of Noopept in experimental models of cognitive impairment.” Journal of Neural Transmission, 121(8), 957–965.
Label-- Molecular Structure and Data
| Property | Value |
|---|---|
| Peptide | J-147 |
| Chemical Name | N-(2,4-dimethylphenyl)-2,2,2-trifluoro-N’-(3-methoxybenzyl)hydrazine |
| Molecular Formula | C₁₈H₁₇F₃N₂O₂ |
| Molecular Weight | 350.34 g/mol |
| CAS Number | 1146963-51-0 |
| Property | Value |
|---|---|
| Peptide | Dihexa |
| Chemical Name | N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide |
| Molecular Formula | C₂₇H₄₄N₄O₅ |
| Molecular Weight | 504.7 g/mol |
| CAS Number | 1401708-83-5 |
| Property | Value |
|---|---|
| Peptide | Noopept |
| Chemical Name | N-phenylacetyl-L-prolylglycine ethyl ester |
| Molecular Formula | C₁₇H₂₂N₂O₄ |
| Molecular Weight | 318.4 g/mol |
| CAS Number | 157115-85- |
Dosage--
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals.
This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use in humans. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides.
Store in a dry and dark place at room temperature, out of reach of small children.
Additional Taxes may apply for shipping to GCC
100% Authentic
Made in USA
Authorised distributor
1 - 5 days delivery
Click to read - How we deliver to India
Disclaimer
Product Information Sheet
: Not a diet substitute. Seek Medical guidance if unsure before use.
BioMind - Advanced Neurocognitive Research Complex
Exploring Cognitive Function, Neuroprotection, and Synaptic Plasticity
BioMind is a three-in-one research formulation developed to investigate pathways of neuroplasticity, cognitive resilience, and brain health in preclinical settings. It combines J-147, Dihexa, and Noopept - three complementary neuroactive compounds that together provide a unique framework for studying neural regeneration and cognitive performance.
Key Components of BioMind
- J-147 (10mg per serving*): A neurotrophic compound studied for its ability to modulate mitochondrial function, increase BDNF, and support resilience against oxidative stress.
- Dihexa (10mg per serving*): A synaptogenic agent that promotes neural connectivity and repair, mimicking natural neurotrophic factors.
- Noopept (10mg per serving*): A dipeptide nootropic that supports neurotransmission, memory formation, and neuronal protection.
*Serving size = 2 capsules
Research Focus Areas
- J-147: Investigated for mitochondrial modulation, neuroprotection, and pathways linked to longevity and cognitive resilience.
- Dihexa: Explored for synaptogenesis, neural repair, and enhanced long-term potentiation (LTP).
- Noopept: Studied for its role in neurotransmission, neuroprotection, and cognitive support.
Synergistic Potential
Together, J-147, Dihexa, and Noopept create a multi-target research platform:
- J-147 enhances mitochondrial function and BDNF expression.
- Dihexa promotes synaptic repair and connectivity.
- Noopept amplifies neurotransmission efficiency and memory processes.
This synergy provides a valuable opportunity to study mechanisms of neurodegeneration, cognitive enhancement, and neuronal repair in preclinical models.
Research Insights
J147 and Neuroprotection
J147 is a synthetic compound designed to combat neurodegenerative diseases, particularly Alzheimer’s disease. It has demonstrated the ability to reverse cognitive impairment in aged Alzheimer’s disease mouse models by enhancing memory and synaptic plasticity [1]. Further studies indicate that J147 improves mitochondrial function and reduces markers of brain aging, suggesting its potential as a therapeutic agent for neurodegenerative conditions [2].
Dihexa and Synaptic Growth
Dihexa is an angiotensin IV analog known for its potent neurogenic and synaptogenic effects. Research has shown that Dihexa binds with high affinity to hepatocyte growth factor (HGF), promoting synaptogenesis and enhancing cognitive function in animal models of Alzheimer’s disease [3]. In APP/PS1 mouse models, Dihexa administration rescued cognitive impairment and recovered memory via the PI3K/AKT signaling pathway [4].
Noopept and Cognitive Enhancement
Noopept is a synthetic nootropic compound recognized for its cognitive-enhancing properties. Studies have demonstrated that Noopept improves memory retention and learning capacity in animal models, suggesting its potential in addressing cognitive decline associated with aging and neurodegenerative diseases [5]. Its mechanisms include modulation of glutamatergic transmission and increased expression of neurotrophic factors, which contribute to its neuroprotective and cognitive-enhancing effects [5].
Synergistic Effects of J147, Dihexa, and Noopept
BioMind’s unique formulation combines J147’s neuroprotective properties, Dihexa’s synaptogenic effects, and Noopept’s cognitive enhancement, creating a comprehensive approach to support brain health and function. This synergistic combination offers a multifaceted strategy for promoting neuronal resilience and cognitive performance, addressing synaptic loss, cognitive decline, and neuronal damage concurrently.
Referenced Citations
- Chen, Q., et al. (2013). “The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer’s disease mice.” Alzheimer’s Research & Therapy, 5, 25.
- Currais, A., et al. (2019). “Elevating acetyl-CoA levels reduces aspects of brain aging.” eLife, 8, e47866.
- Benoist, C. C., et al. (2014). “The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-Met system.” Journal of Pharmacology and Experimental Therapeutics, 351(2), 390–402.
- Sun, X., et al. (2021). “AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway.” Frontiers in Aging Neuroscience, 13, 745.
- Ostrovskaya, R. U., et al. (2014). “Neuroprotective properties of Noopept in experimental models of cognitive impairment.” Journal of Neural Transmission, 121(8), 957–965.
Molecular Structure and Data
| Property | Value |
|---|---|
| Peptide | J-147 |
| Chemical Name | N-(2,4-dimethylphenyl)-2,2,2-trifluoro-N’-(3-methoxybenzyl)hydrazine |
| Molecular Formula | C₁₈H₁₇F₃N₂O₂ |
| Molecular Weight | 350.34 g/mol |
| CAS Number | 1146963-51-0 |
| Property | Value |
|---|---|
| Peptide | Dihexa |
| Chemical Name | N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide |
| Molecular Formula | C₂₇H₄₄N₄O₅ |
| Molecular Weight | 504.7 g/mol |
| CAS Number | 1401708-83-5 |
| Property | Value |
|---|---|
| Peptide | Noopept |
| Chemical Name | N-phenylacetyl-L-prolylglycine ethyl ester |
| Molecular Formula | C₁₇H₂₂N₂O₄ |
| Molecular Weight | 318.4 g/mol |
| CAS Number | 157115-85- |
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals.
This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use in humans. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides.
Store in a dry and dark place at room temperature, out of reach of small children.
